The Compounding Pharmacy of America Recalls Recalls by year
A bar chart of the number of recalls naming this company by year.
Recalls by year
Year Recalls 2015 99 2018 1
Download CSV FDA Recall
Terminated
Historical record Class II
Tri-Mix (18/0.6/5.88) (MFG) Injectable, Sterile, Keep Frozen, The Compounding Pharmacy of America, Knoxville, TN by The Compounding Pharmacy of America
Reason
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility Published
September 23, 2015 Distribution
Nationwide
View recall →
FDA Recall
Terminated
Historical record Class II
Tri-Mix (18 mg/0.6 mg/5.88 mcg) Injectable, Sterile, Keep Frozen, The Compounding Pharmacy of America, Knoxville, TN by The Compounding Pharmacy of America
Reason
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility Published
September 23, 2015 Distribution
Nationwide
View recall →
FDA Recall
Terminated
Historical record Class II
Tri-Mix (17.7/0.59/6) (MFG) Injectable, Sterile, Keep Frozen, The Compounding Pharmacy of America, Knoxville, TN by The Compounding Pharmacy of America
Reason
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility Published
September 23, 2015 Distribution
Nationwide
View recall →
FDA Recall
Terminated
Historical record Class II
Tri-Mix (17.7 mg/0.59 mg/6 mcg) Injectable, Sterile, Keep Frozen, The Compounding Pharmacy of America, Knoxville, TN by The Compounding Pharmacy of America
Reason
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility Published
September 23, 2015 Distribution
Nationwide
View recall →
FDA Recall
Terminated
Historical record Class II
Tri-Mix (15 mg/0.5 mg/5 mcg) Injectable, Sterile, Keep Frozen, The Compounding Pharmacy of America, Knoxville, TN by The Compounding Pharmacy of America
Reason
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility Published
September 23, 2015 Distribution
Nationwide
View recall →
FDA Recall
Terminated
Historical record Class II
Testosterone Cypionate 250 mg/ml Injection, Multi-Dose Vial, Sterile, Room Temperature, The Compounding Pharmacy of America, Knoxville, TN by The Compounding Pharmacy of America
Reason
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility Published
September 23, 2015 Distribution
Nationwide
View recall →
FDA Recall
Terminated
Historical record Class II
Testosterone Bi-Blend 50 mg/ml + Estradiol Valerate 2.5 mg/ml Injectable, The Compounding Pharmacy of America, Knoxville, TN by The Compounding Pharmacy of America
Reason
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility Published
September 23, 2015 Distribution
Nationwide
View recall →
FDA Recall
Terminated
Historical record Class II
Testosterone 37.5 mg, Sterile Pellet, The Compounding Pharmacy of America, Knoxville, TN by The Compounding Pharmacy of America
Reason
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility Published
September 23, 2015 Distribution
Nationwide
View recall →
FDA Recall
Terminated
Historical record Class II
Testosterone 30 mg, Sterile Pellet, The Compounding Pharmacy of America, Knoxville, TN by The Compounding Pharmacy of America
Reason
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility Published
September 23, 2015 Distribution
Nationwide
View recall →
FDA Recall
Terminated
Historical record Class II
Testosterone 25 mg, Sterile Pellet, The Compounding Pharmacy of America, Knoxville, TN by The Compounding Pharmacy of America
Reason
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility Published
September 23, 2015 Distribution
Nationwide
View recall →
FDA Recall
Terminated
Historical record Class II
Testosterone 18 mg, Sterile Pellet, The Compounding Pharmacy of America, Knoxville, TN by The Compounding Pharmacy of America
Reason
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility Published
September 23, 2015 Distribution
Nationwide
View recall →
FDA Recall
Terminated
Historical record Class II
MYO-DEN (30 ml) 25 mg/ml Injection, Multi-Dose Vial, Sterile, Room Temperature, The Compounding Pharmacy of America, Knoxville, TN by The Compounding Pharmacy of America
Reason
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility Published
September 23, 2015 Distribution
Nationwide
View recall →
This page lists recalls that name The Compounding Pharmacy of America as the recalling firm in the official source notice. It is
not a safety rating, ranking, or statement that the company acted negligently.
Read the full medical disclaimer .
